<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=DLX2</id>
	<title>DLX2 - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=DLX2"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=DLX2&amp;action=history"/>
	<updated>2026-06-23T01:07:51Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=DLX2&amp;diff=6390&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «Homeobox protein DLX-2  ==Publications==  {{medline-entry |title=A gain-of-function senescence bypass screen identifies the homeobox transcription factor DLX2...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=DLX2&amp;diff=6390&amp;oldid=prev"/>
		<updated>2021-05-12T15:27:58Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «Homeobox protein DLX-2  ==Publications==  {{medline-entry |title=A gain-of-function senescence bypass screen identifies the homeobox transcription factor &lt;a href=&quot;/DLX2&quot; title=&quot;DLX2&quot;&gt;DLX2&lt;/a&gt;...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Homeobox protein DLX-2&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=A gain-of-function senescence bypass screen identifies the homeobox transcription factor [[DLX2]] as a regulator of [[ATM]]-p53 signaling.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26833729&lt;br /&gt;
|abstract=Senescence stimuli activate multiple tumor suppressor pathways to initiate cycle arrest and a differentiation program characteristic of senescent cells. We performed a two-stage, gain-of-function screen to select for the genes whose enhanced expression can bypass replicative senescence. We uncovered multiple genes known to be involved in p53 and Rb regulation and [[ATM]] regulation, two components of the CST (CTC1-[[STN1]]-TEN1) complex involved in preventing telomere erosion, and genes such as [[REST]] and [[FOXO4]] that have been implicated in aging. Among the new genes now implicated in senescence, we identified [[DLX2]], a homeobox transcription factor that has been shown to be required for tumor growth and metastasis and is associated with poor cancer prognosis. Growth analysis showed that [[DLX2]] expression led to increased cellular replicative life span. Our data suggest that [[DLX2]] expression reduces the protein components of the TTI1/TTI2/TEL2 complex, a key complex required for the proper folding and stabilization of [[ATM]] and other members of the PIKK (phosphatidylinositol 3-kinase-related kinase) family kinase, leading to reduced [[ATM]]-p53 signaling and senescence bypass. We also found that the overexpression of [[DLX2]] exhibited a mutually exclusive relationship with p53 alterations in cancer patients. Our functional screen identified novel players that may promote tumorigenesis by regulating the [[ATM]]-p53 pathway and senescence. &lt;br /&gt;
|mesh-terms=* Ataxia Telangiectasia Mutated Proteins&lt;br /&gt;
* Cell Line&lt;br /&gt;
* Cellular Senescence&lt;br /&gt;
* Computational Biology&lt;br /&gt;
* Gene Expression Regulation&lt;br /&gt;
* Homeodomain Proteins&lt;br /&gt;
* Humans&lt;br /&gt;
* Reproducibility of Results&lt;br /&gt;
* Signal Transduction&lt;br /&gt;
* Telomere Homeostasis&lt;br /&gt;
* Transcription Factors&lt;br /&gt;
* Transcriptional Activation&lt;br /&gt;
* Tumor Suppressor Protein p53&lt;br /&gt;
|keywords=* ATM&lt;br /&gt;
* genetic screen&lt;br /&gt;
* senescence&lt;br /&gt;
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743059&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>